INTRODUCTION: Vascularization remains an obstacle to engineering of larger volume bone tissues. Our aim was to induce axial vascularization in a processed bovine cancellous bone (PBCB) matrix using an arteriovenous (AV) loop (artery, vein graft, and vein). METHODS: Custom-made PBCB discs (9 x 5 mm) were implanted into rats. In group A (n = 19), the matrices were inserted into microsurgically constructed AV loops between the femoral vessels using a vein graft from the contralateral side. In group B (n = 19), there was no vascular carrier. The matrices were encased in isolation chambers. After 2, 4, and 8 weeks, the animals were perfused with India ink via the abdominal aorta. Matrices were explanted and subjected to histological and morphometric analysis. Results were compared with intravital dynamic micro & magnetic resonance imaging and scanning electron microscopy images of vascular corrosion replicas. RESULTS: In group A, significant vascularization of the matrix had occurred by the 8th week. At this time, vascular remodeling with organization into vessels of different sizes was evident. Blood vessels originated from all 3 zones of the AV loop. Group A was significantly superior to group B in terms of vascular density and vascularization kinetics. DISCUSSION: This study demonstrates for the first time successful vascularization of solid porous matrices by means of an AV loop. Injection of osteogenic cells into axially prevascularized matrices may eventually create functional bioartificial bone tissues for reconstruction of large defects.
INTRODUCTION: Vascularization remains an obstacle to engineering of larger volume bone tissues. Our aim was to induce axial vascularization in a processed bovine cancellous bone (PBCB) matrix using an arteriovenous (AV) loop (artery, vein graft, and vein). METHODS: Custom-made PBCB discs (9 x 5 mm) were implanted into rats. In group A (n = 19), the matrices were inserted into microsurgically constructed AV loops between the femoral vessels using a vein graft from the contralateral side. In group B (n = 19), there was no vascular carrier. The matrices were encased in isolation chambers. After 2, 4, and 8 weeks, the animals were perfused with India ink via the abdominal aorta. Matrices were explanted and subjected to histological and morphometric analysis. Results were compared with intravital dynamic micro & magnetic resonance imaging and scanning electron microscopy images of vascular corrosion replicas. RESULTS: In group A, significant vascularization of the matrix had occurred by the 8th week. At this time, vascular remodeling with organization into vessels of different sizes was evident. Blood vessels originated from all 3 zones of the AV loop. Group A was significantly superior to group B in terms of vascular density and vascularization kinetics. DISCUSSION: This study demonstrates for the first time successful vascularization of solid porous matrices by means of an AV loop. Injection of osteogenic cells into axially prevascularized matrices may eventually create functional bioartificial bone tissues for reconstruction of large defects.
Authors: Julia Will; Reinhold Melcher; Cornelia Treul; Nahum Travitzky; Ulrich Kneser; Elias Polykandriotis; Raymund Horch; Peter Greil Journal: J Mater Sci Mater Med Date: 2008-02-29 Impact factor: 3.896
Authors: Andreas Arkudas; Jimmy Tjiawi; Oliver Bleiziffer; Lucia Grabinger; Elias Polykandriotis; Justus P Beier; Michael Stürzl; Raymund E Horch; Ulrich Kneser Journal: Mol Med Date: 2007 Sep-Oct Impact factor: 6.354
Authors: M Vielreicher; S Schürmann; R Detsch; M A Schmidt; A Buttgereit; A Boccaccini; O Friedrich Journal: J R Soc Interface Date: 2013-07-17 Impact factor: 4.118
Authors: Adeline Sham; Eliana C Martinez; Sebastian Beyer; Dieter W Trau; Michael Raghunath Journal: Tissue Eng Part A Date: 2015-01-14 Impact factor: 3.845
Authors: Oliver Bleiziffer; Raymund E Horch; Matthias Hammon; Andreas Arkudas; Elisabeth Naschberger; Subha Rath; Galyna Pryymachuk; Justus P Beier; Antonis K Hatzopoulos; Michael Stürzl; Ulrich Kneser Journal: J Cell Mol Med Date: 2009-05 Impact factor: 5.310